The rising cost of insulin has long been in the national spotlight, and Congress, state policymakers and manufacturers have acted in response to this trend. Although these policies delivered meaningful insulin affordability for millions of Americans, some people with diabetes still face barriers. This webinar will provide an overview of these initiatives, consider potential next steps for states and highlight state examples.
Moderator
- Colleen Becker, project manager, NCSL
Speakers
-
Allan Coukell, senior vice president, Public Policy, CivicaRx
-
Sharon Lamberton, deputy vice president, Pharmaceutical and Research Manufacturers of America (PhRMA)
-
State Respondent Representative Elizabeth Thomson, New Mexico